Matthew E. Korenberg, President & COO: Ligand Pharmaceuticals LGND Sell · Filed 24/08/26

Trade details

Type: Insider sale
Amount: $554,139.84
Shares · price: 5,212 sh · $106.32 a share
Held after: 49,510 sh
Stock: Ligand Pharmaceuticals LGND
Person: Matthew E. KorenbergPresident & COO
Trade date: 24/08/26
Filed: 24/08/26
Days to filing: 0 days

Sold 9.5% of holdings

Share of holding sold: 9.5%

Ligand Pharmaceuticals trades, last 26 weeks

What else happened in Ligand Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/07/27~24/09/25

Matthew E. Korenberg's recent trades

Matthew E. KorenbergPresident & COO
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$720.4K
7,090 sh
$720.4K
Filed 24/09/24
Traded 24/09/23
Matthew E. KorenbergPresident & COO
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$653.2K
6,275 sh
$653.2K
Filed 24/09/24
Traded 24/09/20
Matthew E. KorenbergPresident & COO
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$248.2K
2,481 sh
$248.2K
Filed 24/09/24
Traded 24/09/23
Matthew E. KorenbergPresident & COO
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$20.5K
201 sh
$20.5K
Filed 24/09/24
Traded 24/09/23
Matthew E. KorenbergPresident & COO
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$648.7K
6,177 sh
$648.7K
Filed 24/08/26
Traded 24/08/26